Gland Pharma slips 10%, hits 52-week low on disappointing Q1 results

Q1 profit after tax tumbled 35 per cent YoY and 20 per cent QoQ to Rs 229 crore, due to lower operational income

Gland Pharma

Shares of Gland Pharma hit a 52-week low of Rs 2,232 as they slipped 10 per cent on the BSE in Thursday's intra-day trade. The company reported 35 per cent

Also Read

Gland Pharma advances 9% on heavy volumes; stock hits 9-week high

Gland Pharma rides high on valuation comfort, strong growth prospects

Election results 2022: Date, time, how & where to watch counting of votes

Will India Inc see robust Q4 despite input cost pressure?

India Inc likely to see robust Q4 nos despite input cost pressure: Analysts

MARKET LIVE: Sensex, Nifty flat; Wipro sheds 2%, Realty, Metals firm

Stocks to Watch Today: Wipro, IndusInd Bank, Adani Enter, CEAT, Sonata, SBI

Stocks and sectors to bet on as the US economy faces a recession

Insurance stocks: Analysts see decent upside in HDFC Life, ICICI Lombard

Markets surge amid 'peak inflation' optimism, gain now 4% in 4 days

First Published: Jul 21 2022 | 9:53 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to